Skip to main content
. 2015 Nov 16;2(4):273–281. doi: 10.3390/jcdd2040273

Table 3.

Management and follow up.

Patient Initial Ejection Fraction (Percentage) Follow-up Ejection Fraction (Percentage) Administered Medications Follow up (Years) Chest Pain Recurrence Documented CAD on Follow-up
A 45 70 Aspirin, Metoprolol, Pravastatin Ramipril 13 Yes No
B 50 60 Metoprolol, Aspirin 17 No No
C 25 40 Aspirin, Metoprolol, Clopidogrel, Ramipril 9 No No
D 35 55 Aspirin, Lisinopril, Metoprolol, Clopidogrel 8 No No
E 35 55 Metoprolol, Atorvastatin 7 No No
F 35 61 Lisinopril, Carvedilol 10 Yes No
G 50 55 Aspirin, Clopidogrel, Valsartan, Atorvastatin 6 Yes No
H 35 60 Aspirin, Clopidogrel, Metoprolol, Statin 6 No No
I 25 45 Aspirin, Lisinopril, Metoprolol, Statin, 5 No No
J 40 55 Aspirin, Statin, Lisinopril, Amlodipine 5 No No
K 30 50 Aspirin, Metoprolol, Statin, Lisinopril 5 No No
L 25 60 Aspirin, Statin, Carvedilol, Fosinopril ** 8 Yes Yes

** = Progression of CAD from 30% stenosis of RCA that was later found to be 90%.